Similar response was documented in vitro in the non-small cell lung cancer (NSCLC) cell line A549, where PD-L1 expression was upregulated in a time- and dose-dependent manner after treatment of up to four 6 Gy fractions [46]. Here, CD274 is linked to non-small cell lung carcinoma.